Skip to main content

190 77 Pill - peach capsule/oblong, 11mm

Pill with imprint 190 77 is Peach, Capsule/Oblong and has been identified as Capecitabine 150 mg. It is supplied by Teva Pharmaceuticals USA Inc.

Capecitabine is used in the treatment of Colorectal Cancer; Breast Cancer, Metastatic; Breast Cancer; Pancreatic Cancer; Stomach Cancer and belongs to the drug class antimetabolites. There is positive evidence of human fetal risk during pregnancy. Capecitabine 150 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 190 77

Capecitabine 150 mg 190 77
Capecitabine 150 mg 190 77
Capecitabine 150 mg 190 77
Capecitabine 150 mg 190 77


190 77
150 mg
11.00 mm
Prescription only
Drug Class
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Teva Pharmaceuticals USA Inc
Inactive Ingredients
lactose anhydrous, croscarmellose sodium, hypromellose 2910 (3 mPa.s), hypromellose 2910 (6 mPa.s), magnesium stearate, microcrystalline cellulose, ferric oxide red, magnesium silicate, titanium dioxide, ferric oxide yellow

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC Code Labeler / Repackager
00093-7473 Teva Pharmaceuticals USA, Inc.
42291-0190 (Discontinued) AvKare, Inc.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.